• negative regulation of cell proliferation • stem cell differentiation • positive regulation of peptidyl-serine phosphorylation of STAT protein • positive regulation of MAPK cascade • positive regulation of peptidyl-serine phosphorylation • spongiotrophoblast differentiation • 肺発生 • positive regulation of histone H3-K27 acetylation • 多細胞個体の発生 • lung lobe morphogenesis • muscle organ morphogenesis • maternal process involved in female pregnancy • negative regulation of hormone secretion • leukemia inhibitory factor signaling pathway • regulation of metanephric nephron tubule epithelial cell differentiation • regulation of cell differentiation • positive regulation of gene expression • stem cell population maintenance • positive regulation of peptidyl-tyrosine phosphorylation • regulation of RNA polymerase II regulatory region sequence-specific DNA binding • positive regulation of astrocyte differentiation • negative regulation of ERK1 and ERK2 cascade • neuron development • decidualization • positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis • 肺胞発生 • positive regulation of macrophage differentiation • blood vessel remodeling • trophoblast giant cell differentiation • lung vasculature development • positive regulation of transcription from RNA polymerase II promoter • positive regulation of protein localization to nucleus • embryo implantation • negative regulation of meiotic nuclear division • immune response • positive regulation of cell proliferation • positive regulation of tyrosine phosphorylation of STAT protein • tyrosine phosphorylation of STAT protein • regulation of receptor activity • cytokine-mediated signaling pathway
^ abcGRCh38: Ensembl release 89: ENSG00000128342 - Ensembl, May 2017
^ abcGRCm38: Ensembl release 89: ENSMUSG00000034394 - Ensembl, May 2017
^"Human PubMed Reference:".
^"Mouse PubMed Reference:".
^Aghajanova, L (2004). “Leukemia inhibitory factor and human embryo implantation”. Annals of the New York Academy of Sciences1034: 176–83. doi:10.1196/annals.1335.020. PMID 15731310.
^Kawahara Y, Manabe T, Matsumoto M, Kajiume T, Matsumoto M, Yuge L (2009). Zwaka, Thomas. ed. “LIF-Free Embryonic Stem Cell Culture in Simulated Microgravity”. PLoS ONE4 (7): e6343. doi:10.1371/journal.pone.0006343. PMC: 2710515. PMID 19626124. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0006343.
^“CGS : PTO Finds Stem Cell Patent Anticipated, Obvious in Light of 'Significant Guideposts'”. 2013年2月4日閲覧。
推薦文献
Patterson PH (1994). “Leukemia inhibitory factor, a cytokine at the interface between neurobiology and immunology”. Proc. Natl. Acad. Sci. U.S.A.91 (17): 7833–5. doi:10.1073/pnas.91.17.7833. PMC: 44497. PMID 8058719. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC44497/.
Aghajanova L (2005). “Leukemia inhibitory factor and human embryo implantation”. Ann. N. Y. Acad. Sci.1034: 176–83. doi:10.1196/annals.1335.020. PMID 15731310.
Králícková M, Síma P, Rokyta Z (2005). “Role of the leukemia-inhibitory factor gene mutations in infertile women: the embryo-endometrial cytokine cross talk during implantation--a delicate homeostatic equilibrium”. Folia Microbiol. (Praha)50 (3): 179–86. doi:10.1007/BF02931563. PMID 16295654.
Stahl J, Gearing DP, Willson TA, et al. (1990). “Structural organization of the genes for murine and human leukemia inhibitory factor. Evolutionary conservation of coding and non-coding regions”. J. Biol. Chem.265 (15): 8833–41. PMID 1692837.
Bazan JF (1991). “Neuropoietic cytokines in the hematopoietic fold”. Neuron7 (2): 197–208. doi:10.1016/0896-6273(91)90258-2. PMID 1714745.
Lowe DG, Nunes W, Bombara M, et al. (1989). “Genomic cloning and heterologous expression of human differentiation-stimulating factor”. DNA8 (5): 351–9. doi:10.1089/dna.1.1989.8.351. PMID 2475312.
Sutherland GR, Baker E, Hyland VJ, et al. (1989). “The gene for human leukemia inhibitory factor (LIF) maps to 22q12”. Leukemia3 (1): 9–13. PMID 2491897.
Mori M, Yamaguchi K, Abe K (1989). “Purification of a lipoprotein lipase-inhibiting protein produced by a melanoma cell line associated with cancer cachexia”. Biochem. Biophys. Res. Commun.160 (3): 1085–92. doi:10.1016/S0006-291X(89)80114-7. PMID 2730639.
Gough NM, Gearing DP, King JA, et al. (1988). “Molecular cloning and expression of the human homologue of the murine gene encoding myeloid leukemia-inhibitory factor”. Proc. Natl. Acad. Sci. U.S.A.85 (8): 2623–7. doi:10.1073/pnas.85.8.2623. PMC: 280050. PMID 3128791. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC280050/.
Williams RL, Hilton DJ, Pease S, et al. (1989). “Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells”. Nature336 (6200): 684–7. doi:10.1038/336684a0. PMID 3143916.
Moreau JF, Donaldson DD, Bennett F, et al. (1989). “Leukaemia inhibitory factor is identical to the myeloid growth factor human interleukin for DA cells”. Nature336 (6200): 690–2. doi:10.1038/336690a0. PMID 3143918.
Yamaguchi M, Miki N, Ono M, et al. (1995). “Inhibition of growth hormone-releasing factor production in mouse placenta by cytokines using gp130 as a signal transducer”. Endocrinology136 (3): 1072–8. doi:10.1210/en.136.3.1072. PMID 7867561.
Schmelzer CH, Harris RJ, Butler D, et al. (1993). “Glycosylation pattern and disulfide assignments of recombinant human differentiation-stimulating factor”. Arch. Biochem. Biophys.302 (2): 484–9. doi:10.1006/abbi.1993.1243. PMID 8489250.
Aikawa J, Ikeda-Naiki S, Ohgane J, et al. (1997). “Molecular cloning of rat leukemia inhibitory factor receptor alpha-chain gene and its expression during pregnancy”. Biochim. Biophys. Acta1353 (3): 266–76. PMID 9349722.
Hinds MG, Maurer T, Zhang JG, et al. (1998). “Solution structure of leukemia inhibitory factor”. J. Biol. Chem.273 (22): 13738–45. doi:10.1074/jbc.273.22.13738. PMID 9593715.
“Toward a complete human genome sequence”. Genome Res.8 (11): 1097–108. (1999). doi:10.1101/gr.8.11.1097. PMID 9847074.
Tanaka M, Hara T, Copeland NG, et al. (1999). “Reconstitution of the functional mouse oncostatin M (OSM) receptor: molecular cloning of the mouse OSM receptor beta subunit”. Blood93 (3): 804–15. PMID 9920829.
Nakashima K, Yanagisawa M, Arakawa H, et al. (1999). “Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300”. Science284 (5413): 479–82. doi:10.1126/science.284.5413.479. PMID 10205054.
Dunham I, Shimizu N, Roe BA, et al. (1999). “The DNA sequence of human chromosome 22”. Nature402 (6761): 489–95. doi:10.1038/990031. PMID 10591208.
PDBギャラリー
1emr: CRYSTAL STRUCTURE OF HUMAN LEUKEMIA INHIBITORY FACTOR (LIF)
1pvh: Crystal structure of leukemia inhibitory factor in complex with gp130
…patients treated with tyrosine kinase inhibitors, the disease culminates in an acute leukemia, termed "blast crisis." Prior to the availability of tyrosine kinase inhibitors, this phase, which is generally refractory …
… does not directly inhibit members of the SRC kinase family , dasatinib and bosutinib inhibit both BCR-ABL1 and SRC kinases. Nilotinib is an inhibitor of BCR-ABL1,… myeloid leukemia (CML) is a myeloproliferative disorder associated with the Philadelphia chromosome t(9;22)(q34;q11) resulting in the BCR-ABL1 fusion gene.…
… cell leukemia (HCL) is an uncommon lymphoid neoplasm characterized by the accumulation of small mature B… Vemurafenib and dabrafenib are potent BRAF inhibitors used in the treatment of metastatic or unresectable melanoma.…
… and a JAK2 inhibitor (TG101209) increased apoptosis and decreased the leukemia-initiating activity of these progenitors in immunodeficient recipients (NSG mice) . In addition to inhibiting JAK2 in CML …
… childhood leukemia and is much less common in the pediatric population than acute lymphoblastic leukemia (ALL), which accounts for 80 percent of pediatric acute leukemia.… addition of the FLT3 inhibitor midostaurin to conventional chemotherapy was safe and improved outcomes for patients with FLT3-ITD mutations . FLT3 inhibitors have been shown to be…